Details of the Drug Reposition

General Information of This Drug (ID: DMRBA5F)

Drug Name
Staphylococcus aureus vaccine   DMRBA5F

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2/3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bacterial infection DIS5QJ9S 1A00-1C4Z Phase 2/3 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Staphylococcus infection DISY8WGS 1B5Y Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Microbiol. 2012 Feb 22;2:16.
2 ClinicalTrials.gov (NCT01160172) A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults. U.S. National Institutes of Health.